71 related articles for article (PubMed ID: 2684003)
1. Selection bias in clinical trials of anaplastic glioma.
Winger MJ; Macdonald DR; Schold SC; Cairncross JG
Ann Neurol; 1989 Oct; 26(4):531-4. PubMed ID: 2684003
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy management of patients diagnosed with glioma in Victoria (1998-2000): a retrospective cohort study.
Dally M; Rosenthal M; Drummond K; Murphy M; Cher L; Ashley D; Thursfield V; Giles G
J Med Imaging Radiat Oncol; 2009 Jun; 53(3):318-24. PubMed ID: 19624300
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of re-irradiation in malignant glioma: a single-center experience.
Bartsch R; Weitmann HD; Pennwieser W; Wenzel C; Muschitz S; Baldass M; Hassler M; Marosi C; Rössler K; Pötter R; Dieckmann K
Wien Klin Wochenschr; 2005 Dec; 117(23-24):821-6. PubMed ID: 16437319
[TBL] [Abstract][Full Text] [Related]
4. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
Würschmidt F; Bünemann H; Heilmann HP
Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
[TBL] [Abstract][Full Text] [Related]
6. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
[TBL] [Abstract][Full Text] [Related]
7. Gliomatosis cerebri: treatment results with radiotherapy alone.
Elshaikh MA; Stevens GH; Peereboom DM; Cohen BH; Prayson RA; Lee SY; Barnett GH; Suh JH
Cancer; 2002 Nov; 95(9):2027-31. PubMed ID: 12404298
[TBL] [Abstract][Full Text] [Related]
8. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
9. Rationale for carbon ion therapy in high-grade glioma based on a review and a meta-analysis of neutron beam trials.
Maucort-Boulch D; Baron MH; Pommier P; Weber DC; Mizoe JE; Rochat J; Boissel JP; Balosso J; Tsujii H; Amsallem E
Cancer Radiother; 2010 Jan; 14(1):34-41. PubMed ID: 20004126
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
11. [The European experience with megadose therapy and autologous bone marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ cell tumors and brain tumors)].
Ladenstein R; Gadner H; Hartmann O; Pico J; Biron P; Thierry P
Wien Med Wochenschr; 1995; 145(2-3):55-7. PubMed ID: 7762255
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
13. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
14. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
[TBL] [Abstract][Full Text] [Related]
15. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
Gabayan AJ; Green SB; Sanan A; Jenrette J; Schultz C; Papagikos M; Tatter SP; Patel A; Amin P; Lustig R; Bastin KT; Watson G; Burri S; Stea B
Neurosurgery; 2006 Apr; 58(4):701-9; discussion 701-9. PubMed ID: 16575334
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
17. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
[TBL] [Abstract][Full Text] [Related]
18. Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years?
Anderson E; Grant R; Lewis SC; Whittle IR
Br J Neurosurg; 2008 Jun; 22(3):339-49. PubMed ID: 18568722
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemoradiotherapy with weekly paclitaxel in malignant cerebral glioma treatment.
Montemor JP; Peria FM; Monti CR; Petrilli LS; Colli BO; Carlotti Júnior CG
Onkologie; 2008 Sep; 31(8-9):435-9. PubMed ID: 18787350
[TBL] [Abstract][Full Text] [Related]
20. [The problem of long survival in malignant gliomas (author's transl)].
Giordana MT; Schiffer D
Pathologica; 1978; 70(1009-1010):663-8. PubMed ID: 755238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
